» Articles » PMID: 31489964

MicroRNA-26b Inhibits Oligodendrocyte Precursor Cell Differentiation by Targeting Adrenomedullin in Spinal Cord Injury

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2019 Sep 7
PMID 31489964
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Oligodendrocyte precursor cells (OPCs) serve as a reservoir of newborn oligodendrocytes (OLs) in pathological and homeostatic conditions. After spinal cord injury (SCI), OPCs are activated to generate myelinating OLs, contributing to remyelination and functional recovery; however, the underlying molecular mechanisms remain unclear. Here, microRNA-26b (miR-26b) expression in the spinal cord tissues of SCI rats was examined by real-time polymerase chain reaction analysis. The influences of miR-26b on locomotor recovery following SCI were assessed utilizing Basso, Beattie, and Bresnahan (BBB) scores. The effects of miR-26b on OPC differentiation were explored using immunofluorescence and western blot analyses in vitro and in vivo. The potential targets that are modulated by miR-26b were identified by bioinformatics, luciferase reporter assays, and western blot analyses. The effects of adrenomedullin (ADM) on OPC differentiation were explored in vitro using immunofluorescence and western blot analyses. We demonstrated that miR-26b was significantly downregulated after SCI. BBB scores showed that miR-26b exacerbated the locomotor function deficits induced by SCI. In vitro, miR-26b inhibited the differentiation of primary rat OPCs. In vivo, miR-26b suppressed OPC differentiation in SCI rats. Bioinformatics analyses and experimental detection revealed that miR-26b directly targeted ADM in OPCs. In addition, knockdown of ADM suppressed the differentiation of primary rat OPCs. Our study provides evidence that ADM may mediate miR-26b-inhibited OPC differentiation in SCI.

Citing Articles

The therapeutic potential of microRNAs to ameliorate spinal cord injury by regulating oligodendrocyte progenitor cells and remyelination.

Qiu S, Dai H, Wang Y, Lv Y, Yu B, Yao C Front Cell Neurosci. 2024; 18:1404463.

PMID: 38812792 PMC: 11135050. DOI: 10.3389/fncel.2024.1404463.


Spinal Cord Injury: From MicroRNAs to Exosomal MicroRNAs.

Xu X, Liu R, Li Y, Zhang C, Guo C, Zhu J Mol Neurobiol. 2024; 61(8):5974-5991.

PMID: 38261255 DOI: 10.1007/s12035-024-03954-7.


Epigenetic mechanism of miR-26b-5p-enriched MSCs-EVs attenuates spinal cord injury.

Xu J, Ren Z, Niu T, Li S Regen Ther. 2023; 25:35-48.

PMID: 38058606 PMC: 10696431. DOI: 10.1016/j.reth.2023.10.005.


Regulation of Glial Function by Noncoding RNA in Central Nervous System Disease.

Bai Y, Ren H, Bian L, Zhou Y, Wang X, Xiong Z Neurosci Bull. 2022; 39(3):440-452.

PMID: 36161582 PMC: 10043107. DOI: 10.1007/s12264-022-00950-6.


MicroRNAs: emerging driver of cancer perineural invasion.

Zhang M, Xian H, Dai L, Tang Y, Liang X Cell Biosci. 2021; 11(1):117.

PMID: 34187567 PMC: 8243427. DOI: 10.1186/s13578-021-00630-4.